Glaxo's Trizivir approved for HIV

The FDA granted marketing approval for Glaxo's Trizivir, a combination pill of Retrovir zidovudine AZT, Ziagen abacavir and BioChem Pharma's Epivir lamivudine 3TC, to treat HIV infection. Glaxo (GLX; ...